Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 2, 2007, Pages 146-150

  Lamsa R ^a,c   Helisalmi, S ^a   Herukka, S K ^a   Tapiola, T ^b   Pirttila T ^a,b   Vepsalainen S ^a   Hiltunen, M ^a   Soininen, H ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NONE   (Finland)

Author keywords

1q25; Acyl coenzyme A:cholesterol acyltransferase 1; Alzheimer's disease, genetics; Biological markers

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; CHOLESTEROL ACYLTRANSFERASE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENDER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STEROL O-ACYLTRANSFERASE; TAU PROTEINS;

EID: 34447617331     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000105164     Document Type: Article

References (20)

1. Li BL, Li XL, Duan ZJ, Lee O, Lin S, Ma ZM, Chang CC, Yang XY, Park JP, Mohandas TK, Noll W, Chan L, Chang TY: Human acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) gene organization and evidence that the 4.3-kilobase ACAT-1 mRNA is produced from two different chromosomes. J Biol Chem 1999;274:16:11060-11071.
2. Puglielli L, Konopka G, Pack-Chung E, Ingano LA, Berezovska O, Hyman BT, Chang TY, Tanzi RE, Kovacs DM: Acyl-coenzyme A:cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol 2001;3:10:905-912.
3. Hutter-Paier B, Huttunen HJ, Puglielli L, Eckman CB, Kim DY, Hofmeister A, Moir RD, Domnitz SB, Frosch MP, Windisch M, Kovacs DM: The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 2004;44:2:227-238.
4. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM; ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Investigators: Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 2006;354:12:1253-1263.
5. Wollmer MA, Streffer JR, Tsolaki M, Grimaldi LM, Lutjohann D, Thal D, von Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A: Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease. Mol Psychiatry 2003;8:6:635-638.
6. Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, Lutjohann D, Nitsch RM, Hock C: A cluster of cholesterolrelated genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry 2005;66:7:940-947.
7. Bertram L, Hsiao M, Mullin K, Parkinson M, Menon R, Moscarillo TJ, Blacker D, Tanzi RE: ACAT1 is not associated with Alzheimer's disease in two independent family-based samples. Mol Psychiatry 2005;10:6:522-524.
8. Zhao FG, Wang YH, Yang JF, Ma QL, Tang Z, Dong XM, Chan P: Association between acyl-coenzyme A:cholesterol acyltransferase gene and risk for Alzheimer's disease in Chinese. Neurosci Lett 2005;388:1:17-20.
9. Blomqvist ME, Reynolds C, Katzov H, Feuk L, Andreasen N, Bogdanovic N, Blennow K, Brookes AJ, Prince JA: Towards compendia of negative genetic association studies: an example for Alzheimer disease. Hum Genet 2006;119:1-2:29-37.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:7:939-944.
11. Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hanninen T, Ryynanen M, Riekkinen PJ: Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996;46:2:413-419.
12. Purcell S, Cherny SS, Sham PC: Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:1:149-150.
13. Carter CJ: Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Neurochem Int 2007;50:12-38.
14. Cacabelos R, Fernandez-Novoa L, Lombardi V, Kubota Y, Takeda M: Molecular genetics of Alzheimer's disease and aging. Methods Find Exp Clin Pharmacol 2005;27(suppl A):1-573.
15. Gomes I, Collins A, Lonjou C, Thomas NS, Wilkinson J, Watson M, Morton N: Hardy-Weinberg quality control. Ann Hum Genet 1999;63:535-538.
16. Wittke-Thompson JK, Pluzhnikov A, Cox NJ: Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:6:967-986.
17. Nielsen DM, Ehm MG, Weir BS: Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 1998;63:5:1531-1540.
18. Lee WC: Searching for disease-susceptibility loci by testing for Hardy-Weinberg disequilibrium in a gene bank of affected individuals. Am J Epidemiol 2003;158:5:397-400.
19. Oka A, Tamiya G, Tomizawa M, Ota M, Katsuyama Y, Makino S, Shiina T, Yoshitome M, Iizuka M, Sasao Y, Iwashita K, Kawakubo Y, Sugai J, Ozawa A, Ohkido M, Kimura M, Bahram S, Inoko H: Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111 kb segment telomeric to the HLA-C gene. Hum Mol Genet 1999;8:12:2165-2170.
20. Weinberg CR, Morris RW: Invited commentary: testing for Hardy-Weinberg disequilibrium using a genome single-nucleotide polymorphism scan based on cases only. Am J Epidemiol 2003;158:401-403; discussion 404-405.